You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金斯瑞生物科技(01548.HK):傳奇生物後續公開發售已完成

格隆匯7月31日丨金斯瑞生物科技(01548.HK)董事會宣佈,公司非全資附屬公司傳奇生物(其股份以美國存托股份形式於美國納斯達克全球精選市場上市)已通知公司,後續公開發售已於2022年7月29日(紐約時間)(2022年7月29日香港交易時段後)完成。傳奇生物於後續公開發售中發行936.1萬股美國存托股份(每股代表兩股普通股),公開發售價格為每股美國存托股份43美元。完成時發行的美國存托股份數目包括承銷商行使購股權購買額外122.1萬股美國存托股份。

緊隨後續公開發售完成後,公司於傳奇生物的股權被攤薄,由約56.2%減少至53.0%(未計及日後配發及發行僱員股份擁有權計劃股份,並假設傳奇認股權證未獲行使)。傳奇生物將繼續為公司的直接非全資附屬公司,傳奇生物的經營業績及財務狀況將繼續計入集團的合併財務報表。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account